Barclays »

Recursion Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.6M 697k 6.59
2024-06-30 $3.4M 453k 7.50
2024-03-31 $3.1M 314k 9.97
2023-12-31 $5.9M 597k 9.86
2023-09-30 $4.3M 558k 7.65
2023-06-30 $1.4M 189k 7.47
2023-03-31 $1.3M 188k 6.67
2022-12-31 $2.3M 297k 7.71
2022-09-30 $1.2M 112k 10.65
2022-06-30 $166k 21k 8.11
2022-03-31 $165k 23k 7.17